Natixis

Source: SEC Form 13F · as of Mar 2026

Natixis holds 69 biotech & pharma companies tracked by BioSniper, totaling $1.19B in value as of Mar 2026 (SEC Form 13F).

Companies held

69

Total value held

$1.19B

CompanySharesValue
PMPhilip Morris International Inc1,198,571$198.2M
BMYBRISTOL MYERS SQUIBB CO2,068,064$125.4M
LLYELI LILLY & Co100,947$92.8M
ABTABBOTT LABORATORIES778,903$80.0M
NVONovo Nordisk A/S2,005,285$73.7M
CAHCardinal Health Inc.338,711$71.6M
MRKMerck & Co., Inc.510,056$61.4M
GILDGILEAD SCIENCES, INC.406,715$56.7M
PFEPFIZER INC1,912,234$53.7M
JNJJOHNSON & JOHNSON213,825$52.3M
ABBVAbbVie Inc.233,196$50.7M
UNHUnitedHealth Group Incorporated Common Stock (DE)159,577$43.2M
REGNREGENERON PHARMACEUTICALS, INC.55,307$42.7M
ELVElevance Health Inc.119,350$34.9M
ZTSZoetis Inc.281,576$33.3M
GMOptec International, Inc.332,501$24.8M
VRTXVERTEX PHARMACEUTICALS INC / MA48,192$21.5M
IDXXIDEXX LABORATORIES INC /DE18,018$10.1M
AMGNAMGEN INC17,885$6.3M
ALNYALNYLAM PHARMACEUTICALS, INC.17,076$5.6M
NVSNovartis AG36,500$5.6M
DGXQuest Diagnostics Incorporated28,191$5.5M
CORCencora Inc.14,123$4.4M
WSTWest Pharmaceutical Services Inc.17,576$4.4M
SUPNSUPERNUS PHARMACEUTICALS, INC.85,200$4.4M
BIIBBIOGEN INC.22,585$4.1M
MEDPMedpace Holdings Inc.7,948$3.8M
ERASErasca, Inc.163,192$2.6M
VTRSViatris Inc134,531$1.8M
RAREUltragenyx Pharmaceutical Inc.81,754$1.7M
COGTCogent Biosciences, Inc.41,536$1.6M
CAICaris Life Sciences Inc.52,778$944K
PCRXPacira BioSciences, Inc.34,000$768K
HLFHerbalife Ltd.51,700$761K
UTHRUNITED THERAPEUTICS Corp1,175$697K
TECHBIO-TECHNE Corp11,286$590K
EOLSEvolus, Inc.141,437$581K
RIOTRiot Platforms, Inc.41,603$514K
SRPTSarepta Therapeutics, Inc.22,856$497K
RVMDREVOLUTION MEDICINES, INC.4,745$461K
KRYSKrystal Biotech, Inc.1,736$448K
DVADaVita Inc.2,898$445K
TEVATeva Pharmaceutical Industries Limited13,589$409K
IQVIQVIA Holdings Inc.2,345$400K
BAXBaxter International Inc.21,490$361K
ROIVRoivant Sciences Ltd.12,800$355K
NBIXNEUROCRINE BIOSCIENCES INC2,647$349K
GEHCGE HealthCare Technologies Inc.4,513$321K
ACHCAcadia Healthcare Company Inc.6,380$149K
TERNTerns Pharmaceuticals, Inc.2,800$148K
INSPInspire Medical Systems Inc.2,033$105K
HALOHALOZYME THERAPEUTICS, INC.1,216$79K
BBIOBridgeBio Pharma, Inc.879$65K
AXSMAxsome Therapeutics, Inc.301$51K
NKTRNEKTAR THERAPEUTICS685$49K
IOVAIOVANCE BIOTHERAPEUTICS, INC.7,503$26K
SLNOSOLENO THERAPEUTICS INC692$23K
BCYCBICYCLE THERAPEUTICS PLC4,645$21K
LEGNLegend Biotech Corp1,157$21K
ANABANAPTYSBIO, INC333$18K
RNAAtrium Therapeutics Inc.1,292$17K
XOMAXOMA Royalty Corporation372$12K
RDYDR REDDYS LABORATORIES LTD726$10K
CORTCORCEPT THERAPEUTICS INC81$3K
IMRXImmuneering Corp380$2K
NEONeoGenomics Inc.150$1K
KROSKeros Therapeutics, Inc.100$1K
UPBUpstream Bio, Inc.120$1K
GOSSGossamer Bio, Inc.920$302

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Natixis — Biotech 13F Holdings & Portfolio | BioSniper